MARKET

DXCM

DXCM

Dexcom Inc
NASDAQ
66.54
+0.17
+0.26%
After Hours: 66.44 -0.1 -0.15% 17:07 01/02 EST
OPEN
66.63
PREV CLOSE
66.37
HIGH
67.49
LOW
66.12
VOLUME
2.89M
TURNOVER
--
52 WEEK HIGH
93.25
52 WEEK LOW
54.11
MARKET CAP
25.95B
P/E (TTM)
37.62
1D
5D
1M
3M
1Y
5Y
1D
2 Healthcare Stocks for Long-Term Investors and 1 We Find Risky
Barchart · 1d ago
2 Growth Stocks to Buy For 2026 and Beyond
The Motley Fool · 12/30/2025 13:20
3 Stocks Likely to Gain From Rising HSA Contribution & Medicare Premium
NASDAQ · 12/30/2025 12:33
DexCom call volume above normal and directionally bullish
TipRanks · 12/29/2025 19:25
DexCom Issues Correction for Dexcom G6 and G6 Pro Software
Benzinga · 12/29/2025 18:49
FDA- DEXCOM ISSUES CORRECTION FOR DEXCOM G6 AND G6 PRO SOFTWARE
Reuters · 12/29/2025 18:44
Weekly Report: what happened at DXCM last week (1222-1226)?
Weekly Report · 12/29/2025 09:37
DexCom, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before December 26, 2025 to Discuss Your Rights - DXCM
PR Newswire · 12/26/2025 14:00
More
About DXCM
DexCom, Inc. is a medical device company. The Company is primarily focused on the design, development, and commercialization of continuous glucose monitoring (CGM), systems for the management of diabetes and metabolic health by patients, caregivers, and clinicians. Its products include Dexcom G6, Dexcom G7, Stelo, Dexcom Share, and Dexcom ONE. The Company enables people to take control of health through innovative biosensing technology. Dexcom G6 is its integrated continuous glucose monitoring system (iCGM). Stelo is designed specifically for people with type II diabetes who do not use insulin as the first over-the-counter glucose biosensor in the United States. The Dexcom Share remote monitoring system, offered for use with any Dexcom system, uses an app on the patient’s compatible mobile device. Its Dexcom G7 is for adults and children (2+ years) living with type I or type II diabetes who are on any insulin or medications, at risk of hypoglycemia, and those with gestational diabetes.

Webull offers DexCom Inc stock information, including NASDAQ: DXCM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, DXCM stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading DXCM stock methods without spending real money on the virtual paper trading platform.